日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Generation and validation of a novel multitarget small molecule in glioblastoma.

胶质母细胞瘤新型多靶点小分子的生成与验证

Artetxe-Zurutuza Aizpea, Iturrioz-Rodriguez Nerea, Elizazu Joseba, Toledano-Pinedo Mireia, Porro-Pérez Alicia, De Goñi Irati, Elua-Pinin Alejandro, Schäker-Hübner Linda, Azkargorta Mikel, Elortza Felix, Iriepa Isabel, Lòpez-Muñoz Francisco, Moncho-Amor Veronica, Hansen Finn K, Sampron Nicolás, Marco-Contelles Jose Luis, Matheu Ander

Chaperone-Mediated Autophagy Controls Proteomic and Transcriptomic Pathways to Maintain Glioma Stem Cell Activity

分子伴侣介导的自噬控制蛋白质组学和转录组学途径以维持胶质瘤干细胞活性

Jaione Auzmendi-Iriarte, Maddalen Otaegi-Ugartemendia, Estefania Carrasco-Garcia, Mikel Azkargorta, Antonio Diaz, Ander Saenz-Antoñanzas, Joaquin Andrés Andermatten, Mikel Garcia-Puga, Idoia Garcia, Alejandro Elua-Pinin, Irune Ruiz, Nicolas Sampron, Felix Elortza, Ana Maria Cuervo, Ander Matheu

CRISPR/Cas9 Deletion of SOX2 Regulatory Region 2 (SRR2) Decreases SOX2 Malignant Activity in Glioblastoma

CRISPR/Cas9 删除 SOX2 调节区 2 (SRR2) 可降低胶质母细胞瘤中的 SOX2 恶性活性

Ander Saenz-Antoñanzas, Veronica Moncho-Amor, Jaione Auzmendi-Iriarte, Alejandro Elua-Pinin, Karine Rizzoti, Robin Lovell-Badge, Ander Matheu

Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital

MGMT 启动子甲基化不能预测多诺斯蒂亚医院胶质母细胞瘤患者对替莫唑胺的反应

Larraitz Egaña, Jaione Auzmendi-Iriarte, Joaquin Andermatten, Jorge Villanua, Irune Ruiz, Alejandro Elua-Pinin, Paula Aldaz, Arrate Querejeta, Cristina Sarasqueta, Felix Zubia, Ander Matheu, Nicolas Samprón

P11.46 Discovery of a new HDAC6 inhibitor for the treatment of glioblastoma

P11.46 发现一种用于治疗胶质母细胞瘤的新型 HDAC6 抑制剂

Castel, Pau; Toska, Eneda; Auzmendi-Iriarte, J; Saenz-Antoñanzas, A; Andermatten, J; Elua-Pinin, A; Aldaba, E; Vara, Y; Matheu, A